Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients. Issue 2 (February 2022)
- Record Type:
- Journal Article
- Title:
- Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients. Issue 2 (February 2022)
- Main Title:
- Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients
- Authors:
- Igarashi, Emiko
Tani, Hideki
Tamura, Kosuke
Itamochi, Masae
Shimada, Takahisa
Saga, Yumiko
Inasaki, Noriko
Hasegawa, Sumiyo
Yazawa, Shunsuke
Sasajima, Hitoshi
Kaya, Hiroyasu
Nomura, Satoshi
Itoh, Hiroyuki
Takeda, Shin-ichi
Yamamoto, Yoshihiro
Yamashiro, Seiji
Ichikawa, Tomomi
Horie, Yukio
Hirota, Kojiro
Hirano, Norikazu
Kawashiri, Chikako
Oishi, Kazunori - Abstract:
- Abstract: Genetic testing using reverse transcriptase real-time polymerase chain reaction (rRT-PCR) is the mainstay of diagnosis of COVID-19. However, it has not been fully investigated whether infectious viruses are contained in SARS-CoV-2 genome-positive specimens examined using the rRT-PCR test. In this study, we examined the correlation between the threshold Cycle (Ct) value obtained from the rRT-PCR test and virus isolation in cultured cells, using 533 consecutive clinical specimens of COVID-19 patients. The virus was isolated from specimens with a Ct value of less than 30 cycles, and the lower the Ct value, the more efficient the isolation rate. A cytopathic effect due to herpes simplex virus type 1 contamination was observed in one sample with a Ct value of 35 cycles. In a comparison of VeroE6/TMPRSS2 cells and VeroE6 cells used for virus isolation, VeroE6/TMPRSS2 cells isolated the virus 1.7 times more efficiently than VeroE6 cells. There was no significant difference between the two cells in the mean Ct value of the detectable sample. In conclusion, Lower Ct values in the PCR test were associated with higher virus isolation rates, and VeroE6/TMPRSS2 cells were able to isolate viruses more efficiently than VeroE6 cells.
- Is Part Of:
- Journal of infection and chemotherapy. Volume 28:Issue 2(2022)
- Journal:
- Journal of infection and chemotherapy
- Issue:
- Volume 28:Issue 2(2022)
- Issue Display:
- Volume 28, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 28
- Issue:
- 2
- Issue Sort Value:
- 2022-0028-0002-0000
- Page Start:
- 347
- Page End:
- 351
- Publication Date:
- 2022-02
- Subjects:
- SARS-CoV-2 -- COVID-19 -- Virus isolation -- Threshold cycle (Ct) value -- VeroE6/TMPRSS2 -- Clinical specimens
Chemotherapy -- Periodicals
Infection -- Periodicals
Communicable diseases -- Chemotherapy -- Periodicals
615.5805 - Journal URLs:
- http://www.sciencedirect.com/science/journal/1341321X ↗
http://link.springer-ny.com/link/service/journals/10156/index.htm ↗
http://www.springerlink.com/content/1341-321x ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1016/j.jiac.2021.10.028 ↗
- Languages:
- English
- ISSNs:
- 1341-321X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.691000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20360.xml